Fig. 8: Schematic illustration of the current study.

EIF4B Ser93 phosphorylation by ERK2 promotes mesenchymal markers translation to drive CRC metastasis, while inhibition of ERK2 by Vx-11e suppresses eIF4B phosphorylation at Ser93 site and facilitates eIF4B degradation by ubiquitination, and thus inhibiting EMT and tumor metastasis (Created with BioRender. com).